Moreover, OC was prevented in mice given an IL-13 receptor subunit alpha-2 (IL-13Rα2) fusion protein that neutralises IL-13 bioactivity [10], alluding to the possible involvement of IL-13 signalling in the exacerbation of IBD in both pre-clinical models and patients [20]. The gene discussed is IL13; the disease is inflammatory bowel disease.